Dose-ranging Study of SPL7013 Gel for the Prevention of Bacterial Vaginosis (BV)

NCT01437722 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

205

Enrollment

INDUSTRY

Sponsor class

Conditions

Recurrent Bacterial Vaginosis (BV)

Interventions

DRUG: 1% SPL7013 Gel
DRUG: 3% SPL7013 Gel
DRUG: placebo gel

Sponsor

Starpharma Pty Ltd